Marksans Pharma Limited (MARKSANS.BO)

INR 314.2

(-2.1%)

Market Cap (In INR)

142.38 Billion

Revenue (In INR)

21.77 Billion

Net Income (In INR)

3.13 Billion

Avg. Volume

273.08 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
126.05-358.5
PE
-
EPS
-
Beta Value
1.665
ISIN
INE750C01026
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Mark B. Saldanha
Employee Count
-
Website
https://marksanspharma.com
Ipo Date
Details
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.